Comparison of Aquaporin -4, -5, -9 and IL-8 Levels in GCF, Dentin Fluid and Pulp Samples
Launched by KIRIKKALE UNIVERSITY · Apr 20, 2025
Trial Information
Current as of July 21, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the levels of specific proteins (called Aquaporins and IL-8) in different types of dental tissue and fluids. The researchers want to see how these levels change in people with healthy teeth compared to those with a painful condition known as irreversible pulpitis, which is a serious inflammation of the tooth pulp. The goal is to understand if there is a connection between these protein levels and the state of the teeth.
To participate in this study, you must be between 18 and 64 years old and scheduled for routine root canal treatment at the Kırıkkale University Dental School. You should not have any known health issues or be pregnant. Participants will provide samples of dental tissue and fluids before their treatment begins, and these will be tested in a lab. This research could help improve our understanding of dental health and how to better treat conditions like pulpitis in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients aged 18 to 64 years.
- • Patients without any known systemic disease.
- • Patients requiring root canal treatment for prosthetic purposes (Healthy pulp group).
- • Patients with third molars (wisdom teeth) indicated for extraction due to orthodontic or other clinical reasons (Healthy pulp group).
- • Patients diagnosed with symptomatic irreversible pulpitis based on the criteria established by the American Association of Endodontists (AAE) (Symptomatic irreversible pulpitis group).
- • Patients scheduled for routine root canal treatment at the Department of Endodontics, Faculty of Dentistry, Kırıkkale University.
- • Patients who have provided written informed consent to participate in the study.
- Exclusion Criteria:
- • Patients with any known systemic disease.
- • Pregnant women or those suspected of being pregnant.
- • Patients who have used antibiotics, anti-inflammatory drugs, or antidepressants within the past 4 weeks.
- • Patients with significant dental plaque or calculus, gingival redness or bleeding, severe gingivitis, generalized periodontitis, or periodontal pockets deeper than 4 mm.
- • Patients with teeth showing internal or external root resorption.
- • Patients for whom complete rubber dam isolation cannot be achieved.
- • Patients with teeth exhibiting signs of necrosis, apical lesions, swelling, or presence of a sinus tract.
- • Patients with immature teeth presenting open apices.
- • Patients with third molars (wisdom teeth) that are not fully erupted or have been previously diagnosed with pericoronitis.
About Kırıkkale University
Kırıkkale University is a distinguished academic institution based in Turkey, recognized for its commitment to advancing medical research and education. The university actively engages in clinical trials aimed at enhancing healthcare outcomes and contributing to the scientific community. With a focus on innovation and collaboration, Kırıkkale University leverages its multidisciplinary expertise to conduct rigorous clinical studies that address pressing health challenges. Its research initiatives are guided by ethical standards and a dedication to improving patient care through evidence-based findings.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
TANSU M BEŞPARMAK, PhD student
Principal Investigator
Kirikkale University, Faculty of Dentistry
ALİ ERDEMİR, PROF
Study Chair
Kirikkale University, Faculty of Dentistry
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported